Kadimastem Ltd

OTCPK:KMST.F Stock Report

Market Cap: US$5.5m

Kadimastem Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Asaf Shiloni

Chief executive officer

₪1.6m

Total compensation

CEO salary percentage55.0%
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure7yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Asaf Shiloni's remuneration changed compared to Kadimastem's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-₪12m

Sep 30 2023n/an/a

-₪15m

Jun 30 2023n/an/a

-₪17m

Mar 31 2023n/an/a

-₪20m

Dec 31 2022₪2m₪899k

-₪23m

Sep 30 2022n/an/a

-₪24m

Jun 30 2022n/an/a

-₪25m

Mar 31 2022n/an/a

-₪26m

Dec 31 2021₪2m₪822k

-₪26m

Compensation vs Market: Asaf's total compensation ($USD435.23K) is below average for companies of similar size in the US market ($USD667.63K).

Compensation vs Earnings: Asaf's compensation has been consistent with company performance over the past year.

CEO

Asaf Shiloni (54 yo)

3.3yrs

Tenure

₪1,636,000

Compensation

Mr. Asaf Shiloni serves as the Chief Executive Officer at Kadimastem Ltd since February 01, 2021. Mr. Shiloni has biotech executive experience and a deep knowledge of the cell therapy industry. Mr. Shiloni...

Leadership Team

NamePositionTenureCompensationOwnership
Asaf Shiloni
Chief Executive Officer3.3yrs₪1.64mno data
Uri Ben-Or
Chief Financial Officer2yrs₪222.00kno data
Arik Hasson
Executive Vice President of Business Development12.1yrs₪585.00k0.056%
$ 3.1k
Michal Izrael
Vice President of Research & Development for ALS and Neurodegenerative Diseases7yrs₪626.00k0.040%
$ 2.2k
Michel Revel
Co-Founderno data₪540.00k27.31%
$ 1.5m
Yossi Ben-Yossef
Honorary President & Strategic Consultant15.4yrs₪1.72mno data
Olivier Samuel
VP of European Business Development & Directorno data₪146.00k0.0048%
$ 264.2

7.0yrs

Average Tenure

54yo

Average Age

Experienced Management: KMST.F's management team is seasoned and experienced (7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michel Revel
Co-Founder13.8yrs₪540.00k27.31%
$ 1.5m
Olivier Samuel
VP of European Business Development & Director3.5yrs₪146.00k0.0048%
$ 264.2
Jeanne Loring
Member of Scientific Advisory Boardno datano datano data
Benjamin Reubinoff
Member of Scientific Advisory Boardno datano datano data
Ronen Twito
Chairman of the Board3.5yrs₪781.00kno data
Tamar Galili
Director2.4yrsno datano data
Eddy Karnieli
Member of Scientific Advisory Boardno datano datano data
Danielle Melloul
Member of Scientific Advisory Boardno datano datano data
Tamir Hur
Member of Scientific Advisory Boardno datano datano data
Joseph Itskovitz-Eldor
Member of Scientific Advisory Boardno data₪283.00kno data
Shimon Efrat
Member of Scientific Advisory Boardno datano datano data
Liora Oren
Independent External Director1.7yrsno datano data

3.5yrs

Average Tenure

51yo

Average Age

Experienced Board: KMST.F's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/09 19:53
End of Day Share Price 2024/03/12 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kadimastem Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution